Medicare Enrolled
Dr. Ranbir Dhillon, M.D.
Neurology · Attleboro, MA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dhillon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dhillon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dhillon
Dr. Ranbir Dhillon is a neurology specialist in Attleboro, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dhillon performed 14,099 Medicare services across 1,090 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dhillon received a total of $242,288 from 84 pharmaceutical and/or device companies across 1796 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dhillon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in MA
$242,288 industry payments
Medicare Practice Summary
Medicare Utilization ↗14,099
Medicare services
Top 4% in MA for neurology
1,090
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~705 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
12,636 | $5 | $8 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
345 | $63 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
290 | $90 | $263 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
123 | $104 | $275 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
87 | $135 | $409 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $138 | $325 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
78 | $67 | $161 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
67 | $96 | $250 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
60 | $40 | $100 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
46 | $52 | $200 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $40 | $100 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
27 | $83 | $112 |
| Balance and posture test A test to evaluate a patient's balance and posture. This assessment measures stability and body alignment. |
20 | $29 | $160 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
20 | $45 | $300 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
19 | $372 | $650 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
17 | $79 | $200 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
17 | $105 | $180 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
17 | $28 | $100 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
16 | $29 | $100 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $91 | $200 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
15 | $142 | $500 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
15 | $174 | $600 |
| New patient office visit, complex (60-74 min) | 15 | $171 | $531 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $128 | $526 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
13 | $60 | $76 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$242,288
Total received (2018-2024)
Avg $34,613/year across 7 years
Top 3% in MA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
1,796
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$137,976 (56.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$70,461 (29.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$33,851 (14.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$15,874
2023
$16,611
2022
$28,325
2021
$23,360
2020
$26,955
2019
$64,630
2018
$66,532
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$7,585
E.R. Squibb & Sons, L.L.C.
$1,883
ABBVIE INC.
$840
Novartis Pharmaceuticals Corporation
$759
Lundbeck LLC
$476
EMD Serono, Inc.
$372
Alexion Pharmaceuticals, Inc.
$367
Merz Pharmaceuticals, LLC
$340
PFIZER INC.
$339
Amneal Pharmaceuticals LLC
$280
SK Life Science, Inc.
$277
Lilly USA, LLC
$274
Teva Pharmaceuticals USA, Inc.
$206
Biogen, Inc.
$200
UCB, Inc.
$196
Genentech USA, Inc.
$164
ACADIA Pharmaceuticals Inc
$156
GENZYME CORPORATION
$118
Neurelis, Inc.
$92
Vanda Pharmaceuticals Inc.
$90
LivaNova USA, Inc.
$85
Mallinckrodt Hospital Products Inc.
$83
Eisai Inc.
$81
Kyowa Kirin, Inc.
$81
Inspire Medical Systems, Inc.
$75
Sumitomo Pharma America, Inc.
$65
Otsuka America Pharmaceutical, Inc.
$60
Amgen Inc.
$57
MDD US Operations, LLC
$56
TG Therapeutics, Inc.
$35
Grifols USA, LLC
$29
ARGENX US, INC.
$26
MITSUBISHI TANABE PHARMA AMERICA, INC.
$23
Neurocrine Biosciences, Inc.
$22
Ipsen Biopharmaceuticals, Inc
$21
CSL Behring
$21
JAZZ PHARMACEUTICALS INC.
$15
WATERMARK MEDICAL, INC.
$13
Life Molecular Imaging Ltd
$13
Top 3 companies account for 64.9% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$69,873
GENZYME CORPORATION
$53,088
Teva Pharmaceuticals USA, Inc.
$32,041
Celgene Corporation
$27,078
E.R. Squibb & Sons, L.L.C.
$21,346
EMD Serono, Inc.
$4,225
Genentech USA, Inc.
$3,810
Novartis Pharmaceuticals Corporation
$3,682
LivaNova USA, Inc.
$2,841
Acorda Therapeutics, Inc
$2,501
Lundbeck LLC
$2,163
SK Life Science, Inc.
$1,720
Janssen Pharmaceuticals, Inc
$1,142
UCB, Inc.
$1,141
ABBVIE INC.
$1,102
Neurocrine Biosciences, Inc.
$867
Merz Pharmaceuticals, LLC
$833
Alexion Pharmaceuticals, Inc.
$785
Biohaven Pharmaceuticals, Inc.
$768
Amneal Pharmaceuticals LLC
$648
Neurelis, Inc.
$644
PFIZER INC.
$634
Lilly USA, LLC
$626
AbbVie Inc.
$569
Amgen Inc.
$553
Sunovion Pharmaceuticals Inc.
$525
Biohaven Pharmaceutical Holding Company Ltd.
$519
CSL Behring
$469
Supernus Pharmaceuticals, Inc.
$446
Kyowa Kirin, Inc.
$414
Mallinckrodt LLC
$370
Eisai Inc.
$370
ACADIA Pharmaceuticals Inc
$307
Grifols USA, LLC
$302
Mallinckrodt Hospital Products Inc.
$278
MDD US Operations, LLC
$274
Vanda Pharmaceuticals Inc.
$233
Sumitomo Pharma America, Inc.
$218
Mallinckrodt Enterprises LLC
$213
US WorldMeds, LLC
$199
Allergan, Inc.
$192
Adamas Pharmaceuticals, Inc.
$180
Ipsen Biopharmaceuticals, Inc
$178
ARGENX US, INC.
$133
EISAI INC.
$114
BANNER LIFE SCIENCES, LLC
$88
Xeris Pharmaceuticals, Inc.
$87
SANOFI-AVENTIS U.S. LLC
$83
Merz North America, Inc.
$80
Otsuka America Pharmaceutical, Inc.
$78
Medtronic USA, Inc.
$77
Inspire Medical Systems, Inc.
$75
IMPEL PHARMACEUTICALS INC.
$72
Upsher-Smith Laboratories LLC
$64
MERZ NORTH AMERICA, INC.
$55
CATALYST PHARMACEUTICALS, INC.
$54
Medtronic, Inc.
$48
NEUROPACE, INC.
$48
Horizon Therapeutics plc
$47
ANI Pharmaceuticals, Inc.
$45
Bayer HealthCare Pharmaceuticals Inc.
$45
Bardy Diagnostics, Inc.
$45
Allergan Inc.
$45
GE HealthCare
$43
Impax Laboratories, Inc.
$42
MITSUBISHI TANABE PHARMA AMERICA, INC.
$37
Avion Pharmaceuticals
$37
UPSHER-SMITH LABORATORIES LLC
$36
TG Therapeutics, Inc.
$35
Avanir Pharmaceuticals, Inc.
$32
GE HEALTHCARE
$28
Life Molecular Imaging Ltd
$27
ARBOR PHARMACEUTICALS, INC.
$26
Genentech, Inc.
$24
Vertical Pharmaceuticals, LLC
$20
Mitsubishi Tanabe Pharma America, Inc.
$20
Mylan Pharmaceuticals Inc.
$20
Egalet US Inc
$19
Jazz Pharmaceuticals Inc.
$18
Pernix Therapeutics Holdings, Inc.
$18
JAZZ PHARMACEUTICALS INC.
$15
WATERMARK MEDICAL, INC.
$13
Banner Life Sciences, LLC
$12
Strongbridge US INC.
$12
Top 3 companies account for 64.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · ARES 620 UNICORDER · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · CREXONT · Carnation Ambulatory Monitor · Cenobamate · DISEASE STATE · Dhivy · Dysport · EMGALITY · EPIDIOLEX · Enspryng · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gocovri · HETLIOZ · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LATUDA · LEMTRADA · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MEROCEL · MYOBLOC · Mavenclad · NEURACEQ · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · Ozanimod · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · REYVOW · RNS Neurostimulator Kit · RYTARY · Rystiggo · SILENOR · SKYCLARYS · SPRIX · SUNOSI · SYNCHROMED · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · Vimpat · XADAGO · XCOPRI · XEOMIN · Xadago · Xeomin · ZAVZPRET · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (57%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in MA.
Geographic Context
Neurologists within 10 mi
143
Per 100K population
24.7
County median income
$84,198
Nearest hospital
STURDY MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dhillon is a mixed practice specialist, with above-average Medicare volume (top 4% in MA), with speaking/promotional industry engagement in the top 3% of MA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dhillon experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Dhillon performed 12,636 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dhillon receive payments from pharmaceutical companies?
Yes. Dr. Dhillon received a total of $242,288 from 84 companies across 1,796 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dhillon's costs compare to other neurologists in Attleboro?
Dr. Dhillon's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dhillon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Attleboro
Browse neurologists in Attleboro ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MA
Which MA neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology